US Lawyer Database

§ 31-52-8. Physician Immunity From Sanction for Recommending, Prescribing, or Treating With Investigational Drugs, Biological Products, or Devices

The Georgia Composite Medical Board shall not revoke, suspend, sanction, fail to renew, or take any other action against a physician’s license solely based on such physician’s recommendation, prescription, or treatment of an eligible patient with an investigational drug, biological product, or device pursuant to this chapter. History. Code 1981, § 31-52-8 , enacted by […]

§ 31-52-9. State Prohibited From Blocking Eligible Patient Access

No official, employee, or agent of the state shall block or attempt to block an eligible patient’s access to an investigational drug, biological product, or device. Counseling, advice, or a recommendation for treatment consistent with medical standards of care shall not be construed as a violation of this Code section. History. Code 1981, § 31-52-9 […]

§ 31-49-1. Legislative Findings

The General Assembly finds and declares that it is estimated that as many as 55,000 Georgia residents suffer from lupus, a life-long autoimmune disease in which the immune system becomes unbalanced, causing inflammation, tissue damage, seizures, strokes, heart attacks, miscarriages, and organ failure. Although anyone can develop lupus, it strikes mostly women of childbearing age; […]

§ 31-52-10. Statutory Construction

This chapter shall not be construed to create a private cause of action against a manufacturer of an investigational drug, biological product, or device or against any other person or entity involved in the care of an eligible patient using an investigational drug, biological product, or device for any harm done to the eligible patient […]

§ 31-53-1. Legislative Findings

The General Assembly finds that Georgia faces population and community health challenges. The current health infrastructure must be adapted to adequately integrate state and private resources in a manner that will serve to maximize the state’s goals, including improved access to care, effective health management strategies, and cost control measures. All components of the state’s […]

§ 31-49-3. Duties and Responsibilities of Council

The council shall have the following duties and responsibilities: To initially investigate the level of education concerning lupus in this state; and Based on the results of its initial investigation pursuant to paragraph (1) of this Code section, to develop information on lupus endorsed by government agencies, including, but not limited to, the National Institutes […]

§ 31-53-2. Definitions

As used in this chapter, the term: “Director” means the director of health strategy and coordination established pursuant to Code Section 31-53-4. “Office” means the Office of Health Strategy and Coordination established pursuant to Code Section 31-53-3. History. Code 1981, § 31-53-2 , enacted by Ga. L. 2019, p. 148, § 2-2/HB 186.

§ 31-49-4. Distribution of Information

The department shall post the information developed by the council pursuant to paragraph (2) of subsection (a) of Code Section 31-49-3 on its website. Subject to appropriations or access to other private or public funds, the department may distribute such information to individuals with lupus, their family members, health care professionals, hospitals, local health departments, […]

§ 31-53-3. Establishment of Office of Health Strategy and Coordination; Powers and Duties

There is established within the office of the Governor the Office of Health Strategy and Coordination. The objective of the office shall be to strengthen and support the health care infrastructure of the state through interconnecting health functions and sharing resources across multiple state agencies and overcoming barriers to the coordination of health functions, including […]